Bariatric Surgery and Long-term Cardiovascular Events
Lars Sjöström(Mercer (Czechia)), Lena Carlsson(University of Gothenburg), Calle Bengtsson(Primary HealthCare), Jan Karlsson, Hans Lönroth, Björn Carlsson, C. David Sjöström(University Medical Center Groningen), Kristjan Karason, Kristina Narbro, Ingmar Näslund(Örebro University Hospital), Sofie Ahlin, Claude Bouchard(Pennington Biomedical Research Center), Torsten Olbers(Sahlgrenska University Hospital), Gerd Bergmark, Markku Peltonen(Karolinska Institutet), Åsa Anveden, Peter Jacobson, S Dahlgren, Per‐Arne Svensson, Anna‐Karin Lindroos(MRC Human Nutrition Research), Hans Wedel(Boston University)
Cited by 1,622
Related Papers
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
|New England Journal of Medicine|2004|4.5k